Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous tissue repair stimulation" refers to strategies and therapies designed to leverage the body's own cells and mechanisms for regenerative healing of injured or diseased tissue. These approaches typically focus on mobilizing endogenous stem/progenitor cells, modulating immune responses (such as macrophage phenotypes), promoting growth factor signaling (e.g., VEGF, BMP), and employing bioengineering interventions (such as electrical stimulation) to facilitate wound closure, tissue growth, and functional restoration. The term does not denote a distinct molecular target or receptor, but encompasses a set of cellular processes and signaling pathways that collectively support tissue regeneration[1][2][3][4][5].
Activation of stem/progenitor cells Modulation of local immune response Enhancement of growth factor signaling (e.g., VEGF, BMP, Wnt-β-catenin pathways)[1][2][3][4] Electrical stimulation to promote cell migration and proliferation[3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous tissue repair stimulation.